TABLE 1.
Description of risk of treatment failure patients who suppressed and were referred to an adherence club.
| Characteristic |
N = 165 |
|||
|---|---|---|---|---|
| N | % | Median | IQR | |
| Gender | ||||
| Males | 30 | 18.2 | - | - |
| Females | 135 | 81.8 | - | - |
| Age ART start | - | - | 30.7 | 27.6–37.1 |
| Age | ||||
| 16–19 | 3 | 1.8 | - | - |
| 20–24 | 16 | 9.7 | - | - |
| 25–34 | 89 | 54.9 | - | - |
| 35–44 | 45 | 27.3 | - | - |
| 45+ | 12 | 7.3 | - | - |
| Age ART start | - | - | 36.2 | 32.2–32.4 |
| Categorical | ||||
| 16–19 | 0 | 0.0 | - | - |
| 20–24 | 1 | 0.6 | - | - |
| 25–34 | 66 | 40.0 | - | - |
| 35–44 | 69 | 41.8 | - | - |
| 45+ | 29 | 17.6 | - | - |
| Year of ART start | ||||
| 2002–2005 | 27 | 16.4 | - | - |
| 2006–2008 | 56 | 33.9 | - | - |
| 2009–2010 | 51 | 30.9 | - | - |
| 2011–2013 | 31 | 18.8 | - | - |
| Regimen at AC start | ||||
| First line | 28 | 21.1 | - | |
| Second line | 105 | 79.0 | - | |
| Median time from ART start to ROTF, years | - | - | 3.4 | 2.1–5.5 |
| Median time from ART start to AC start, years | - | - | 4.7 | 3.4–7.2 |
| Median time from ROTF start to AC start, years | - | - | 1.2 | 1.0–1.5 |
ART, antiretroviral therapy; IQR, interquartile range; AC, adherence club; ROTF, risk of treatment failure.